Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer (HBC)

This is an interventional treatment trial for Breast Cancer focused on measuring Adjuvant hormonal therapy, Homeopathic treatment, Hot flashes, Quality of life, Hot flash score Read More

Inclusion Criteria:

• Female patient aged ≥ 18 years
• Women with histologically proven non metastatic breast cancer
• ECOG PS ≤ 1
• Patient receiving adjuvant hormonal therapy for at least 1 month (aromatase inhibitor or Tamoxifen ± ovarian function suppression (Luteinizing Hormone Releasing Hormone agonist (LH-RH agonist), ovariectomy...))
• Patient complaining of hot flashes with moderate to severe intensity, affecting quality of life, for at least 1 month before inclusion
• Patient agreement not to start another hot flash treatment during the study (allopathic treatment, E vitamin, dietary supplement, phytotherapy, acupuncture...)
• Patient able to understand, read and write French
• Mandatory affiliation with a health insurance system
• Signed, written informed consent

Exclusion Criteria:

• Ongoing chemotherapy or radiotherapy, or treatment planned to begin during the study
• Patient with a condition known to induce hot flashes such as hyperthyroidism, diabetes, adrenal tumor, enteric carcinoid tumor, mastocytosis...
• Patient with severe renal failure, severe hepatic failure, or cardiovascular disease

• Patient with one of the following contraindications:

  • known hypersensitivity to one of the components of the study drug
  • galactose, fructose intolerance
  • Lapp lactase deficiency, isomaltase invertase deficiency
  • Glucose or galactose malabsorption syndrome
• Follow up impossible because of social, familial, geographical or psychological reasons
• Patient suspected of poor compliance with protocol or treatment
• Participation in another biomedical research trial in the same indication, or administration of an experimental drug in the same indication in the 30 days before inclusion